PACS vs FMS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PACS · PACS Group$49.60 ▼ 1.20%
FMS · Fresenius Medical Care$23.40 ▼ 1.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PACS +296.8%
- FMS +2.7%
Head to head
| Metric | PACS | FMS |
|---|---|---|
| Price | $49.60 | $23.40 |
| Change today | ▼ 1.20% | ▼ 1.10% |
| Market cap | $7.87B | $12.15B |
| Return, 3 months | +2.4% | -3.9% |
| Return, year to date | +29.2% | +2.2% |
| Return, 1 year | +302.6% | +1.4% |
| P/E (TTM) | 28.2 | 14.0 |
| P/B | 6.5 | 0.8 |
| P/E percentile vs own 5y | 58th | 19th |
| Dividend yield | – | 3.62% |
| Revenue growth (YoY, latest qtr) | +9.1% | +1.4% |
| Net profit growth (YoY) | +49.8% | +7.7% |
| Gross margin | 16.6% | 26.4% |
| Operating margin | 7.4% | 10.2% |
| Net margin | 4.8% | 4.8% |
| Return on equity | 28.1% | 7.3% |
| Analyst target vs. price | +16.9% | +2.6% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 60 | 58 |
| 30-day volatility | 44.4% | 41.0% |
| Max drawdown, 1 year | -27.9% | -25.8% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- FMS is the largest of the group by market value.
- PACS has returned the most over the past year.
- FMS carries the lowest trailing P/E.
- PACS is growing revenue fastest.
- PACS keeps the most profit per dollar of sales.
- FMS has been the calmest stock over the last 30 days.